Table 1 Clinicopathological characteristics of Rwandan patients with gastric cancer (n = 95)
From: The spectrum of TP53 mutations in Rwandan patients with gastric cancer
Characteristics | Number of cases | Percentage |
|---|---|---|
Age (y.o.) | Â | Â |
Mean ± standard deviation |  | (60.6 ± 13.7) |
Range |  | (29–99) |
Age group | Â | Â |
< 45 | 15 | 15.8% |
45–54 | 16 | 16.8% |
55–64 | 23 | 24.2% |
65–74 | 25 | 26.3% |
75- | 16 | 16.8% |
Sex | Â | Â |
Female | 51 | 53.7% |
Male | 44 | 46.3% |
Anatomic site of the tumor | Â | Â |
Cardia | 8 | 8.4% |
Sub-cardia | 3 | 3.2% |
Fundus | 12 | 12.6% |
Corpus | 3 | 3.2% |
Corpus-antrum | 2 | 2.1% |
Antrum | 54 | 56.8% |
Antro-pyloric region | 4 | 4.2% |
Pylorus | 9 | 9.5% |
Lauren’s classification |  |  |
Intestinal | 22 | 23.2% |
Indeterminate | 6 | 6.3% |
Diffuse | 24 | 25.3% |
Mixed | 36 | 37.9% |
Not defined | 7 | 7.4% |
WHO classification | Â | Â |
Papillary | 5 | 5.3% |
Tubular, well-differentiated | 1 | 1.1% |
Tubular, moderately differentiated | 16 | 16.8% |
Tubular, poorly differentiated | 6 | 6.3% |
Poorly cohesive, signet-ring cell phenotype | 7 | 7.4% |
Poorly cohesive, other cell types | 17 | 17.9% |
Mixed | 36 | 37.9% |
Undifferentiated carcinoma | 5 | 5.3% |
Neuroendocrine carcinoma | 2 | 2.1% |